|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 39/395 | |
| C07K 16/22 | |||
| A61K 35/768 | |||
| A61P 35/00 |
| (11) | Number of the document | 3056216 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15154629.8 |
| Date of filing the European patent application | 2015-02-11 | |
| (97) | Date of publication of the European application | 2016-08-17 |
| (45) | Date of publication and mention of the grant of the patent | 2017-02-01 |
| (46) | Date of publication of the claims translation |
| (72) |
GELETNEKY, Karsten, DE
ROMMELAERE, Jean, DE
WICK, Wolfgang, DE
WICK, Antje, DE
DAHM, Michael, DE
|
| (73) |
Deutsches Krebsforschungszentrum,
Im Neuenheimer Feld 280, 69120 Heidelberg,
DE
Ruprecht-Karls-Universität, Grabengasse 1, 69117 Heidelberg, DE |
| (54) | Cancer therapy with a parvovirus combined with bevacizumab |
| Cancer therapy with a parvovirus combined with bevacizumab |